RightFit
Not yet recruitingNot applicable

Assessing Psoriasis Treatment Outcomes

Assessing Psoriasis Treatment Outcomes: a Single-center, Prospective Study Evaluating Patient Outcomes in Psoriasis

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Phone or video check-ins, Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "To evaluate medication adherence over a 4-week period in patients with psoriasis randomized to weekly AI-generated automated physician providers (AIGPP) video interactions, weekly human video calls, or standard care (single follow up visit after 4 weeks)."
  • "Subjects who meet inclusion criteria will complete a demographic questionnaire and will be randomized to one of three arms (1."
  • "AI intervention group - patients will receive BD and have a weekly virtual visit with an AIGPP, 2. human intervention group - patients will receive BD and receive weekly video calls from study staff, 3. standard of care group - patients will receive BD and scheduled for a single follow up visit in 4 weeks)."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This 4-week study is for adults with psoriasis, a skin condition, who can use betamethasone medicine on their skin. It compares weekly AI-generated doctor videos, weekly video calls with a person, and usual care with one follow-up visit after 4 weeks. The study looks at trust, comfort, the patient-doctor relationship, and medicine use, tracked by a special cap on the medicine container.

To assess the feasibility of AIGPP video interactions with psoriasis patients. To explore patient attitudes, trust, and comfort levels concerning AIGPP interactions in a healthcare setting, and to understand their influence on the patient-physician dynamic. To evaluate medication adherence over a 4-week period in patients with psoriasis randomized to weekly AI-generated automated physician providers (AIGPP) video interactions, weekly human video calls, or standard care (single follow up visit after 4 weeks). Adherence rates will be evaluated via a cap designed to record adherence attached to the study medication container.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • You are age 18 or older.
  • You have psoriasis that can be treated with betamethasone medicine applied to the skin.
  • You live in the United States.
  • You understand and use English well enough to take part.
  • You have a mobile device that can run video at 25 frames per second or more.

Who can't join

  • You are younger than 18.
  • You have other serious health conditions or health conditions that are not stable.
  • You are pregnant or breastfeeding.
  • You have another skin condition that could make it hard for the study doctor to judge your skin.
  • You are using other psoriasis treatments, such as skin medicines, medicines that work throughout the body, or light therapy.
  • You do not have a mobile device that can run video at 25 frames per second or more.
  • You do not have psoriasis that can be treated with betamethasone medicine applied to the skin.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Patients ≥18 years of age * Patients with a current diagnosis of psoriasis suitable for treatment with topical Betamethasone (BD) * Patients who live in the United States * Patients with a sufficient command of the English language * Patients with a mobile device able to at least operate at 25 frames per second (FPS). Exclusion Criteria: * Patients less than the age of 18 * Patients with severe or unstable comorbid conditions * Patient who are pregnant or breastfeeding * Patients with any other skin conditions that prohibit or confound the ability of the investigator to interpret skin findings * Patients that are taking concomitant topical or systemic therapy for the treatment of psoriasis and/or phototherapy * Patients without mobile devices able to at least operate at 25 frames per second (FPS). * Patients without a current diagnosis of psoriasis suitable for treatment with topical BD

Study sites (1)

NC